PCM
NXTC icon

Penserra Capital Management’s NextCure NXTC Stock Holding History

Penserra Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-53
Closed -$4K – 1489
2021
Q3 		$4K Hold
53
– – ﹤0.01% 1422
2021
Q2 		$5K Buy
53
+2
+4% +$205 ﹤0.01% 1318
2021
Q1 		$6K Sell
51
-2
-4% -$290 ﹤0.01% 1077
2020
Q4 		$6K Buy
+53
New +$6.85K ﹤0.01% 973

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Penserra Capital Management's NXTC Position: Q4 2021 in Review

Penserra Capital Management sold out of NextCure (NXTC) in Q4 2021, closing a stake of 53 shares — an estimated $4K sold.

Penserra Capital Management first reported a position in NXTC in Q4 2020 and held it in 4 quarters. The position peaked at $6K in Q1 2021. 71 funds tracked by Wall St. Rank hold NXTC as of Q4 2021.

  • Penserra Capital Management reported no remaining NextCure position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 53 NextCure shares in Q4 2021, an estimated $4K.
  • Penserra Capital Management first reported a position in NextCure in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's NextCure position peaked at $6K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.